Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide

Current Drug Metabolism

Saved in:
Bibliographic Details
Main Authors: Yang, X.-X., Hu, Z.-P., Chan, S.Y., Ho, P.C.-L., Boelsterli, U.A., Ng, K.-Y., Chan, E., Chen, Y.-Z., Zhou, S.-F., Duan, W., Bian, J.-S., Huang, M.
Other Authors: PHARMACY
Format: Review
Published: 2011
Subjects:
Online Access:http://scholarbank.nus.edu.sg/handle/10635/28977
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
id sg-nus-scholar.10635-28977
record_format dspace
spelling sg-nus-scholar.10635-289772023-08-25T08:30:30Z Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide Yang, X.-X. Hu, Z.-P. Chan, S.Y. Ho, P.C.-L. Boelsterli, U.A. Ng, K.-Y. Chan, E. Chen, Y.-Z. Zhou, S.-F. Duan, W. Bian, J.-S. Huang, M. PHARMACY BIOCHEMISTRY PHARMACOLOGY Irinotecan (CPT-11) Metabolism Pharmacokinetics SN-38 Thalidomide Toxicity Transport Current Drug Metabolism 7 4 431-454 CDMUB 2011-11-29T06:11:42Z 2011-11-29T06:11:42Z 2006 Review Yang, X.-X., Hu, Z.-P., Chan, S.Y., Ho, P.C.-L., Boelsterli, U.A., Ng, K.-Y., Chan, E., Chen, Y.-Z., Zhou, S.-F., Duan, W., Bian, J.-S., Huang, M. (2006). Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide. Current Drug Metabolism 7 (4) : 431-454. ScholarBank@NUS Repository. 13892002 http://scholarbank.nus.edu.sg/handle/10635/28977 000238931800008 Scopus
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
topic Irinotecan (CPT-11)
Metabolism
Pharmacokinetics
SN-38
Thalidomide
Toxicity
Transport
spellingShingle Irinotecan (CPT-11)
Metabolism
Pharmacokinetics
SN-38
Thalidomide
Toxicity
Transport
Yang, X.-X.
Hu, Z.-P.
Chan, S.Y.
Ho, P.C.-L.
Boelsterli, U.A.
Ng, K.-Y.
Chan, E.
Chen, Y.-Z.
Zhou, S.-F.
Duan, W.
Bian, J.-S.
Huang, M.
Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
description Current Drug Metabolism
author2 PHARMACY
author_facet PHARMACY
Yang, X.-X.
Hu, Z.-P.
Chan, S.Y.
Ho, P.C.-L.
Boelsterli, U.A.
Ng, K.-Y.
Chan, E.
Chen, Y.-Z.
Zhou, S.-F.
Duan, W.
Bian, J.-S.
Huang, M.
format Review
author Yang, X.-X.
Hu, Z.-P.
Chan, S.Y.
Ho, P.C.-L.
Boelsterli, U.A.
Ng, K.-Y.
Chan, E.
Chen, Y.-Z.
Zhou, S.-F.
Duan, W.
Bian, J.-S.
Huang, M.
author_sort Yang, X.-X.
title Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
title_short Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
title_full Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
title_fullStr Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
title_full_unstemmed Pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
title_sort pharmacokinetic mechanisms for reduced toxicity of irinotecan by coadministered thalidomide
publishDate 2011
url http://scholarbank.nus.edu.sg/handle/10635/28977
_version_ 1775625570717007872